Oncko

Dixit, Parnas,....Regev

Large scale perturbation + single cell RNA-seq screens. Shuffle-seq outperforms this for combo scale

Dixit, Feldman, Kuksenko, Regev

Novel tech platform for 1 billion scale combination drug screens was applied to discovering drug resistance mechanisms.

Anastopoulos...Dixit

Predict adverse event probabilities using demographics, genetics, and multi-drug profiles from the UKBB and FDA FAERS

Palmer...Sorger

Successful cancer cures have low cross resistance in vitro

Our Publications